Enhanced safety surveillance of the adjuvanted respiratory syncytial virus vaccine among Italian older adults

An adjuvanted vaccine to prevent lower respiratory tract disease caused by respiratory syncytial virus (RSV) in older adults has recently become available. Post-authorization safety studies (PASSs) conducted under real-world conditions complement data obtained from clinical trials characterized by s...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Alexander Domnich, Andrea Orsi, Piero Luigi Lai, Elvira Massaro, Carlo-Simone Trombetta, Julieta Pastorino, Charlott Roihl, Sara Tardito, Marianna Pianta, Giancarlo Icardi, Donatella Panatto
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier 2025-06-01
Sarja:	Vaccine: X
Aiheet:	Respiratory syncytial virus RSV RSV vaccine Arexvy Safety Elderly
Linkit:	http://www.sciencedirect.com/science/article/pii/S2590136225000415
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!